Literature DB >> 3979003

High levels of methylxanthines in chocolate do not alter theobromine disposition.

C A Shively, S M Tarka, M J Arnaud, B H Dvorchik, G T Passananti, E S Vesell.   

Abstract

Theobromine disposition was measured twice in 12 normal men, once after 14 days of abstention from all methylxanthines and once after 1 week of theobromine (6 mg/kg/day) in the form of dark chocolate. Mean theobromine t 1/2, apparent volume of distribution, and clearance after abstinence from all methylxanthines were 10.0 hours, 0.76 L/kg, and 0.88 ml/min/kg. High daily doses of chocolate for 1 week did not change these values. After subjects abstained from methylxanthines, urinary radioactivity over 72 hours after a single, oral dose of [8-14C]theobromine consisted of 42% 7-methylxanthine, 20% 3-methylxanthine, 18% theobromine, 10% 7-methyluric acid, and 10% 6-amino-5[N-methylformylamino]-1-methyluracil. A week of daily theobromine consumption in the form of dark chocolate also did not alter this urinary profile of theobromine and its metabolites. Although these results might appear to differ from other reports of inhibition of theobromine elimination after five consecutive daily doses of theobromine in aqueous suspensions, both the rate and extent of absorption of theobromine in chocolate were less than that of theobromine in solution. Relative bioavailability of theobromine in chocolate was 80% that of theobromine in solution. This reinforces the fundamental principle that both the metabolic and the therapeutic consequences of a particular chemical can differ when that chemical is given in the pure compared with the dietary form.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3979003     DOI: 10.1038/clpt.1985.65

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  7 in total

Review 1.  Blood pressure in relation to coffee and caffeine consumption.

Authors:  Idris Guessous; Chin B Eap; Murielle Bochud
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

2.  Theobromine Upregulates Osteogenesis by Human Mesenchymal Stem Cells In Vitro and Accelerates Bone Development in Rats.

Authors:  Bret H Clough; Joni Ylostalo; Elizabeth Browder; Eoin P McNeill; Thomas J Bartosh; H Ralph Rawls; Tetsuo Nakamoto; Carl A Gregory
Journal:  Calcif Tissue Int       Date:  2016-12-02       Impact factor: 4.333

3.  Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man.

Authors:  A Lelo; D J Birkett; R A Robson; J O Miners
Journal:  Br J Clin Pharmacol       Date:  1986-08       Impact factor: 4.335

Review 4.  Caffeine: cognitive and physical performance enhancer or psychoactive drug?

Authors:  Simone Cappelletti; Daria Piacentino; Piacentino Daria; Gabriele Sani; Mariarosaria Aromatario
Journal:  Curr Neuropharmacol       Date:  2015-01       Impact factor: 7.363

5.  Theobromine inhibits uric acid crystallization. A potential application in the treatment of uric acid nephrolithiasis.

Authors:  Felix Grases; Adrian Rodriguez; Antonia Costa-Bauza
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

Review 6.  Biomarkers of food intake for cocoa and liquorice (products): a systematic review.

Authors:  Charlotte C J R Michielsen; Enrique Almanza-Aguilera; Elske M Brouwer-Brolsma; Mireia Urpi-Sarda; Lydia A Afman
Journal:  Genes Nutr       Date:  2018-07-27       Impact factor: 5.523

7.  Comparison of Two Dietary Supplements for Treatment of Uric Acid Renal Lithiasis: Citrate vs. Citrate + Theobromine.

Authors:  Yumaira Hernandez; Antonia Costa-Bauza; Paula Calvó; Joan Benejam; Pilar Sanchis; Felix Grases
Journal:  Nutrients       Date:  2020-07-07       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.